You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Thousands of imports enter Australia from firms blacklisted by US over alleged Uyghur forced labour links
- 2. Melbourne breast cancer trial to test Optiscan imaging device
- 3. Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance
- 4. Global research trends in tryptophan metabolism and cancer: a bibliometric and visualization analysis (2005–2024)
- 5. Hsa_circ_0001859 promotes NSCLC progression through the miRNA-101-3p/MMP1 axis
- 6. Case Report: Surgical androgen deprivation therapy for prostate cancer in a patient with concurrent scrotal paget's disease
- 7. Peptone Hosts In-Person Advisory Meeting With Leading Experts in Oncology, Drug Development and Medicinal Chemistry to Advance Small Molecule IDP-Targeted Treatment Solutions
- 8. Prostate cancer classification using 3D deep learning and ultrasound video clips: a multicenter study
- 9. Study reveals mechanisms behind common mutation and prostate cancer
- 10. Assessment of prostate cancer aggressiveness through the combined analysis of prostate MRI and 2.5D deep learning models
Last updated at 4:10 GMT
Hot News Makers
Health/Pharma Companies
-
160753.41
-
45153.17
-
21875.74
-
19242.73
-
13056.84
-
10312.28
-
9756.25
-
8043.17
-
7802.56
-
7106.56
Drugs, Treatments, Trials
-
14476.67
-
5432.54
-
4960.96
-
4686.62
-
3641.86
-
3283.21
-
2373.09
-
2173.80
-
2169.62
-
2044.50
Last updated at 3:10 GMT
